Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alster

Showing results (361-370 of 407) with videos related to

Pageof 41
Sort By:
Human Immunology|February 1, 2015
A rare ancestral HLA-DRB1(∗)15:01̃DQB1(∗)02:01 haplotype and its reversion in the same Western European familyThomas M C Binder, Reinhard Kelsch, Julia M Wikner, et al.
Journal of Neuroengineering and Rehabilitation|December 20, 2021
Targeted cognitive game training enhances cognitive performance in multiple sclerosis patients treated with interferon beta 1-aShay Menascu, Roy Aloni, Mark Dolev, et al.
Nature Communications|September 6, 2023
Quantifying thermal adaptation of soil microbial respirationCharlotte J Alster, Allycia van de Laar, Jordan P Goodrich, et al.
The Ocular Surface|July 21, 2023
Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trialStephanie L Watson, Lyndon W Jones, Fiona Stapleton, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 29, 2008
Should lung transplantation be performed using donation after cardiac death? The United States experienceDavid P Mason, Lucy Thuita, Joan M Alster, et al.
Therapeutic Advances in Neurological Disorders|May 26, 2021
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapiesAnat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Harefuah|December 21, 2023
[TUMOR-LIKE EFFECT AS INITIAL PRESENTATION OF PEDIATRIC MULTIPLE SCLEROSIS]Shay Menascu, Amir Pollak, Yehuda Warszawer, et al.
Journal of Neurology|March 2, 2022
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimodAnat Achiron, Mathilda Mandel, Michael Gurevich, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 22, 2006
Full scope of effect of facial lipoatrophy: a framework of disease understandingBenjamin Ascher, Sydney Coleman, Tina Alster, et al.
Critical Care Medicine|November 1, 1984
Comparison of continuous positive airway pressure, incentive spirometry, and conservative therapy after cardiac operationsM C Stock, J B Downs, R B Cooper, et al.
Pageof 41

Showing results (361-370 of 407) with videos related to

Sort By:
Pageof 41
Human Immunology|February 1, 2015
A rare ancestral HLA-DRB1(∗)15:01̃DQB1(∗)02:01 haplotype and its reversion in the same Western European familyThomas M C Binder, Reinhard Kelsch, Julia M Wikner, et al.
Journal of Neuroengineering and Rehabilitation|December 20, 2021
Targeted cognitive game training enhances cognitive performance in multiple sclerosis patients treated with interferon beta 1-aShay Menascu, Roy Aloni, Mark Dolev, et al.
Nature Communications|September 6, 2023
Quantifying thermal adaptation of soil microbial respirationCharlotte J Alster, Allycia van de Laar, Jordan P Goodrich, et al.
The Ocular Surface|July 21, 2023
Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction: A vehicle-controlled, randomized clinical trialStephanie L Watson, Lyndon W Jones, Fiona Stapleton, et al.
The Journal of Thoracic and Cardiovascular Surgery|October 29, 2008
Should lung transplantation be performed using donation after cardiac death? The United States experienceDavid P Mason, Lucy Thuita, Joan M Alster, et al.
Therapeutic Advances in Neurological Disorders|May 26, 2021
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapiesAnat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Harefuah|December 21, 2023
[TUMOR-LIKE EFFECT AS INITIAL PRESENTATION OF PEDIATRIC MULTIPLE SCLEROSIS]Shay Menascu, Amir Pollak, Yehuda Warszawer, et al.
Journal of Neurology|March 2, 2022
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimodAnat Achiron, Mathilda Mandel, Michael Gurevich, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 22, 2006
Full scope of effect of facial lipoatrophy: a framework of disease understandingBenjamin Ascher, Sydney Coleman, Tina Alster, et al.
Critical Care Medicine|November 1, 1984
Comparison of continuous positive airway pressure, incentive spirometry, and conservative therapy after cardiac operationsM C Stock, J B Downs, R B Cooper, et al.
Pageof 41